Additive effects of POLG1 and ANT1 mutations in a complex encephalomyopathy

被引:28
|
作者
Galassi, Giuliana [3 ]
Lamantea, Eleonora [1 ,2 ]
Invernizzi, Federica [1 ,2 ]
Tavani, Federica [4 ]
Pisano, Isabella [5 ]
Ferrero, Ileana [6 ]
Palmieri, Luigi [7 ]
Zeviani, Massimo [1 ,2 ]
机构
[1] IRCCS, C Besta Neurol Inst Fdn, Unit Mol Neurogenet Peirfranco, I-20126 Milan, Italy
[2] IRCCS, C Besta Neurol Inst Fdn, Luisa Mariani Ctr Study Childrens Mitochondrial D, I-20126 Milan, Italy
[3] Univ Modena, Dept Neurosci, I-41100 Modena, Italy
[4] Univ Modena, Serv Neuroradiol, I-41100 Modena, Italy
[5] Univ Bari, Biochem & Mol Biol Lab, Dept Pharmacobiol, Bari, Italy
[6] Univ Parma, Dept Genet Anthropol Evolut, I-43100 Parma, Italy
[7] CNR Inst Biomembranes & Bioenerget, Bari, Italy
关键词
mitochondrial DNA; mtDNA multiple deletions; progressive external ophthalmoplegia; sensory-cerebellar ataxia; ANT1; POLG1;
D O I
10.1016/j.nmd.2008.03.013
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
MtDNA instability is associated with a wide spectrum of clinical presentations, from dominant or recessive progressive external ophthalmoplegia (PEO) to juvenile-onset spino-cerebellar ataxia and epilepsy (SCAE) or infantile Alpers-Huttenlocher syndrome. We present here the clinical and molecular features of a patient with a clinical presentation characterized initially by PEO with mtDNA multiple deletions lately evolving into a severe neurological syndrome, which included sensory and cerebellar ataxia, peripheral neuropathy, parkinsonism, and depression. This complex phenotype is the result of mutations in two distinct proteins, ANTI and Pol gamma A, which cause additive, deleterious effects on mtDNA maintenance and integrity. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:465 / 470
页数:6
相关论文
共 50 条
  • [1] Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO)
    Agostino, A
    Valletta, L
    Chinnery, PF
    Ferrari, G
    Carrara, F
    Taylor, RW
    Schaefer, AM
    Turnbull, DM
    Tiranti, V
    Zeviani, M
    NEUROLOGY, 2003, 60 (08) : 1354 - 1356
  • [2] Clinical and Laboratory Features of a Single Family with Mutations in the POLG1 and ANT1 (SLC25A4) Genes
    Hyams, Lauren C.
    Langley, Geneuieve N.
    Shoffner, John M.
    NEUROLOGY, 2009, 72 (11) : A303 - A303
  • [3] Valproate Is Contraindicated in POLG1 Mutations
    Finsterer, Josef
    PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2019, 22 (01) : 105 - 106
  • [4] Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype: an expanded clinical spectrum of POLG1 mutations
    Sha Tang
    Elliot L. Dimberg
    Margherita Milone
    Lee-Jun C. Wong
    Journal of Neurology, 2012, 259 : 862 - 868
  • [5] Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype: an expanded clinical spectrum of POLG1 mutations
    Tang, Sha
    Dimberg, Elliot L.
    Milone, Margherita
    Wong, Lee-Jun C.
    JOURNAL OF NEUROLOGY, 2012, 259 (05) : 862 - 868
  • [6] Mitochondrial Neurogastrointestinal Encephalomyopathy-Like Phenotypes: An Expanded Clinical Spectrum of POLG1 Mutations
    Tang, Sha
    Dimberg, Elliot
    Milone, Margherita
    Walsh, Laurence
    Kok, Fernando
    Wong, Lee-Jun C.
    NEUROLOGY, 2011, 76 (09) : A579 - A579
  • [7] POLG1, C10ORF2, and ANT1 mutations are uncommon in sporadic progressive external ophthalmoplegia with multiple mitochondrial DNA deletions
    Hudson, G
    Deschauer, M
    Taylor, RW
    Hanna, MG
    Fialho, D
    Schaefer, AM
    He, LP
    Blakely, E
    Turnbull, DM
    Chinnery, PF
    NEUROLOGY, 2006, 66 (09) : 1439 - 1441
  • [8] Phenotypic spectrum of POLG1 mutations
    Josef Finsterer
    Fulvio A. Scorza
    Neurological Sciences, 2018, 39 : 571 - 573
  • [9] Phenotypic spectrum of POLG1 mutations
    Finsterer, Josef
    Scorza, Fulvio A.
    NEUROLOGICAL SCIENCES, 2018, 39 (03) : 571 - 573
  • [10] POLG1 mutations in bipolar disorders
    Finsterer, Josef
    Zarrouk-Mahjoub, Sinda
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2017, 71 (08)